Friday, 4th November Clinical Oncology Society of Australia Annual Scientific Meeting 2022

• The hidden value of supportive care - Mei Krishnasamy
• Defining the social return on investment of telephone cancer information and support services - Nikki McCaffrey
• Social return on investment economic evaluation of supportive care for lung cancer patients in acute care settings in Australia - Amelia Hyatt
• Value of survivorship follow-up care models: what outcomes represent value? - Fiona Crawford-Williams

Followed by Panel discussion

• Indigenous data sovereignty to drive Aboriginal and Torres Strait Islander cancer equity - Kalinda Griffiths
• Lung cancer screening: considerations from an Aboriginal community controlled perspective - Jonathan Gillies

Followed by Panel discussion

• Effect of dietary patterns associated with reduced risk of malnutrition on all-cause and cancer-related mortality: a prospective UK Biobank analysis - Annie R Curtis
• Articulating the gap between the real-world and clinical trial populations – a retrospective analysis of a first-line metastatic colorectal cohort (mCRC) and standard Phase 3 eligibility criteria (EC) - Jun Hee Hong
• An individualised exercise intervention improves quality of life for people with multiple myeloma: the MyeEx randomised waitlist-controlled trial - Jennifer L Nicol
• Improving end-of-life communication for all adolescents and young adults with cancer: a multi-perspective, mixed-methods evaluation of the Voicing My CHOiCES^TM tool. - Ursula M. Sansom-Daly
• Evaluation of quality of life as an early surrogate of overall survival: an analysis from phase 3 immunotherapy trials - Adel Shahnam
• Evaluation of the Fear-Less self-management intervention for managing fear of cancer recurrence - Mei Jun Tran
• A randomised controlled trial evaluating two cognitive rehabilitation approaches for cancer survivors with perceived cognitive impairment   - Janette L Vardy

• Telehealth use in cancer clinical trials during the COVID-19 pandemic - Melissa Austen
• The Australian Cancer Plan: A decision tree approach for assessment against International Standards of National Cancer Control Planning - Daniel Chaji
• Relationship between circulating tumour DNA and skeletal muscle stores at diagnosis of pancreatic ductal adenocarcinoma - Lauren Hanna
• Embedding equity in the Australian Cancer Plan: engaging priority populations to improve equitable outcomes for all Australians - Adam Lambert
• Real-world outcomes in patients receiving upfront docetaxel chemotherapy for metastatic castrate sensitive prostate cancer - Udit Nindra
• Promoting equitable access to specialist head and neck cancer surgical services in regional NSW: cost savings to patients and the health system through provision of outreach clinics - Rebecca L Venchiarutti

• Enhancing access to speech pathology services for rural patients with Head and Neck Cancer - Elizabeth C Ward
• Cancer and Aboriginal and Torres Strait Islander people: creating space through governance and information to better drive health equity in Australia  - Kalinda Griffiths
• LGBTIQ+ people with cancer - Gary Morrison
• Diversity, inclusion and delivering equitable cancer care for all Australians – how do we put it together in clinic next week? - Abhijit Pal

• Lung cancer is a predictor for psychological distress: a longitudinal study. - Shiho Rose
• Stigma and overcoming barriers to lung cancer screening participation – the challenges ahead - Nicole M Rankin
• Talking about smoking: what do we know about minimising shame, blame and guilt? - Christine L Paul
• Stigma and ageism - The challenges of delivering appropriate care to older adults with NSCLC - Christopher Steer

• Pre- and rehabilitation for people with lung cancer: current evidence and future directions - Lara Edbrooke
• Health behaviours of Indigenous and non-Indigenous cancer survivors living in regional and remote geographic areas of Australia - Elaina Elder-Robinson
• CanEAT pathway: a guide to optimal cancer nutrition for people with cancer, carers and health professionals - Jenelle Loeliger
• Essential elements of optimal dietary and exercise referral practices for cancer survivors: Expert consensus for medical and nursing health professionals.   - Ria Joseph

• An assessment of Radiotherapy utilisation, Surgery utilisation and health outcomes, comparing Aboriginal people with non-Aboriginal people with cancer in NSW 2009-2018 - Geoff P Delaney
• The importance of understanding bias: why anti-racist measures are required for First Nations cancer care equity - Ieta D'Costa
• Addressing inequity of access to cancer clinical trials for Aboriginal and Torres Strait Islander people with cancer: Menzies School of Health Research consultancy report for the ReViTALISE project, 2022   - Craig R Underhill
• A communication skills module for non-Indigenous health care professionals supporting Aboriginal and Torres Strait Islander people with cancer - Kerri Lucas and Sophie Mor
• Piloting an Aboriginal and Torres Strait Islander optimal care pathway learning package - Jenny Thresher

• Introduction: where are we now – population cancer data in Queensland - Euan Walpole
• Are some Queenslanders missing out on optimal care? - Shoni Philpot
• Development of a key performance indicator for breast cancer in Queensland, Australia - Michelle Morris
• Understanding the current therapeutic landscape for non-metastatic lung cancer in Queensland - Bryan Chan
• Providing real world evidence to establish a best practice palliative radiation therapy indicator in Queensland - Bryan Burmeister

• Ensuring equity in PRO use in clinical care for Aboriginal and Torres Strait Islander people - Gail Garvey
• When your agency is limited. Uptake of PROs when you have no voice, are sick or are a surrogate for others. - Bena Brown
• The proxy problem and other issues with use of PROs in children’s cancer care - Natalie Bradford
• Health literacy, digital health literacy, and digital inclusion: can digital implementation of PROs reach far enough, and in the right direction? - Emma B Kemp
• Why perfect is the enemy of the good. Implementing PROs into clinical care in the resource limited setting. - Bogda Koczwara

Followed by Panel Discussion

• Multimodal intervention for cachexia in advanced cancer patients undergoing chemotherapy. - Vickie Baracos
• The ECHO trial – exercise during chemotherapy for ovarian cancer - Rosa Spence
• Exercise and dietary intervention to improve the quality of life of women diagnosed with metastatic breast cancer - Marina Reeves

Presenter: The Honourable Greg Hunt